Latest Strategy News

Catapult Group International Ltd reports a standout first half of FY26, delivering record SaaS growth and profitability driven by strong contract renewals and innovative technology integration.

Catapult Sports Ltd has reported a robust first half of FY26, with a 19% increase in Annualized Contract Value and a 50% jump in operating profit, driven by strategic acquisitions and strong SaaS growth.

Catapult Sports Ltd reported a 16.9% revenue increase to US$67.6 million for the half-year ended September 30, 2025, driven by strong subscription growth and key acquisitions. Despite a net loss of US$8.6 million, the company bolstered its cash position and expanded its product suite with AI and remote workflow innovations.

ALS Limited has posted a robust first half for FY26 with underlying EBIT growth of 14.7%, driven by strong performance in its Commodities segment and improved Life Sciences results. The company also raised its interim dividend and updated its growth outlook for the year.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

Serko Limited reports a robust 45% increase in total income for the first half of FY26, driven by its GetThere acquisition and strong momentum in Booking.com for Business, alongside a significant uplift in EBITDAFI.

Finder Energy Holdings has outlined ambitious plans to reach a Final Investment Decision by mid-2026 for its KTJ oil development, aiming for first oil production by late 2027 and unlocking over US$1 billion in gross revenues.

Finder Energy is accelerating development of its Kuda Tasi and Jahal fields in Timor-Leste, aiming for first oil by the end of 2027, backed by strong share price momentum and a clear pathway to production.

Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Airtasker has expanded its US partnership with iHeartMedia, securing an additional US$5 million in media resources and a A$10 million equity investment to accelerate its growth in the American market.

Airtasker Limited has announced a $10 million equity capital raise to accelerate marketing efforts in the UK and US, following a strong first quarter with group revenue up 20.5% year-on-year. Strategic partnerships, including a cornerstone investment from iHeartMedia, underpin its international growth ambitions.